| Application no. and date | 99200695.7 (espacenet) (Federated) (European Patent Register), 19990310 | | Patent/reg. no. and date | DK/EP 0963980, 20020605 | | Publication date | 19991215 | | Priority no. and date | GB 9812413, 19980610 | | EP pub. no. and date |
EP 0963980 19991215 | | Effective date | | | Applicant/owner | THE WELLCOME FOUNDATION LIMITED, Glaxo Wellcome House,
Berkeley Avenue
Greenford,
Middlesex UB6 0NN, GB | | Applicant ref. no. | 32692 DK 01 | | Inventor | Edmeades, Lorraine Mary, c/o Glaxo Wellcome plc.,
Gunnels Wood Road
Stevenage,
Herts. SG1 2NY, GB,
Griffith-Skinner, Nigel Arthur, c/o Glaxo Wellcome plc,
Temple Hill
Dartford,
Ken DA1 5AH, GB,
Hill, Graham Thornton, c/o Glaxo Wellcome plc,
Park Road
Ware,
Herts. SG12 ODP, GB,
Packham, Terrence William, c/o Glaxo Wellcome plc,
Temple Hill
Dartford,
Kent DA1 5AH, GB,
Hill, Derek Anthony, Dodgers Pett Road,
Stockbury
Sittingbourne,
Kent ME9 7RL, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 253/06 (2006.01) , G01N 30/00 (2006.01) , G01N 30/22 (2006.01) , G01N 30/36 (2006.01) , G01N 30/90 (2006.01) , G01N 33/15 (2006.01) | | Title | 1,2,4,-trianzinderivat, fremstilling deraf og anvendelse deraf som referencemarkør til bestemmelse af "lamotrigins"-renhed og stabilitet | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
